Does Intraoperative Hetastarch Administration Increase Blood Loss and Transfusion Requirements After Cardiac Surgery?
- 1 April 2000
- journal article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 90 (4) , 801-807
- https://doi.org/10.1213/00000539-200004000-00006
Abstract
Our large retrospective study suggests that intraoperative use of hetastarch in primary cardiac surgery with cardiopulmonary bypass may increase bleeding and transfusion requirements. A large prospective study is needed to determine if intraoperative administration of hetastarch should be avoided during cardiovascular surgery.Keywords
This publication has 21 references indexed in Scilit:
- A prospective, randomized study of cardiopulmonary bypass temperature and blood transfusion11This article has been selected for the open discussion forum on the STS Web site: http://www.sts.org/section/atsdiscussion/The Annals of Thoracic Surgery, 1999
- The Effect of Hydroxyethyl Starch on Platelet Aggregation In VitroAnesthesia & Analgesia, 1998
- Hydroxyethyl StarchAnesthesia & Analgesia, 1997
- Platelet activation in warm and cold heart surgeryThe Annals of Thoracic Surgery, 1995
- Influence of Different Intravascular Volume Therapies on Platelet Function in Patients Undergoing Cardiopulmonary BypassAnesthesia & Analgesia, 1993
- RETRACTED: Platelet function in cardiac surgery: Influence of temperature and aprotininThe Annals of Thoracic Surgery, 1993
- Hydroxyethyl starch: an alternative to plasma for postoperative volume expansion after cardiac surgeryBritish Journal of Surgery, 1988
- Effects of hydroxyethyl starch on blood coagulation, particularly factor VIIITransfusion, 1985
- Clinical Comparison of Hetastarch and Albumin in Postoperative Cardiac PatientsThe Annals of Thoracic Surgery, 1982
- Hemodynamic, blood volume, and oxygen transport responses to albumin and hydroxyethyl starch infusions in critically ill postoperative patientsCritical Care Medicine, 1980